HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap EUR/ LU1540961916 /
NAV10/30/2024 | Chg.-0.3800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
127.5200EUR | -0.30% | reinvestment | Equity | FundPartner Sol.(EU) ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
11/5/2024 | Public WebStation Live Factsheet | 2024 | English | - |
6/30/2024 | Semi-annual report | 2024 | German | 815.22 KB |
2/19/2024 | PRIIP Key Information Document | 2024 | English | 111.74 KB |
2/19/2024 | PRIIP Key Information Document | 2024 | German | 118.49 KB |
12/31/2023 | Account statment | 2023 | English | 4,345.03 KB |
2/1/2023 | Prospectus | 2023 | English | 848.35 KB |
6/30/2022 | Semi-annual report | 2022 | English | 770.62 KB |
3/1/2021 | Prospectus | 2021 | German | 703.67 KB |
12/31/2019 | Account statment | 2019 | German | 1,047.35 KB |